Emergent advances leukemia therapy to next trial stage Gazette.Net: Maryland Community News Online The trial, which will enroll about 24 patients who have not been treated for chronic lymphocytic leukemia, is designed to test the safety and efficacy of TRU-016 in combination with rituximab, the Rockville biotech said in a statement. The patients ... |
